Emmanuelle Waubant, PhD, MD

Director, Regional Pediatric Multiple Sclerosis Center
Neurologist

Dr. Emmanuelle L. Waubant is a neurologist who specializes in treating patients with multiple sclerosis (MS). She serves as director of the UCSF Regional Pediatric Multiple Sclerosis Center.

Waubant's research focuses on new treatments for MS. She also studies environmental and genetic risk factors, including in children with the disease.

A native of France, Waubant earned her medical degree at the Lille University School of Medicine and completed a residency in neurology at Toulouse University Hospital, where she was chief resident as well as junior faculty for two years. Waubant completed fellowships in neuroimmunology and clinical neuroimmunology at UCSF. She then returned to her native country to head a clinical research center at the Pitie-Salpetriere University Hospital. She joined UCSF's Multiple Sclerosis Center in 2001.

Waubant serves on the clinical care committee of the National Multiple Sclerosis Society's local chapter and on the translational research review committee for the society's national office. She chairs the clinical trial task force and is a member of the steering committee of the International Pediatric Multiple Sclerosis Study Group. A prominent contributor to scientific journals in her field, she is one of two chief editors of Multiple Sclerosis and Related Disorders, and the MS section editor for Annals of Clinical and Translational Neurology.

Waubant is a professor of neurology and pediatrics at UCSF. She speaks French.

Clinics

Multiple Sclerosis Center
1500 Owens St., Suite 320
San Francisco, CA 94158
Phone: (415) 353-2069
Fax: (415) 353-2633

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

Academic Title

Professor

More about Emmanuelle Waubant

Additional Languages

French

Education

Lille University School of Medicine 1992

Residencies

Toulouse University Hospital, Neurology 1992

Fellowships

UCSF Medical Center, Neurology 1999

Selected Research and Publications

  1. Yeh EA, Grover SA, Powell VE, Alper G, Banwell BL, Edwards K, Gorman M, Graves J, Lotze TE, Mah JK, Mednick L, Ness J, Obadia M, Slater R, Waldman A, Waubant E, Schwartz CE. Correction to: Impact of an electronic monitoring device and behavioural feedback on adherence to multiple sclerosis therapies in youth: results of a randomized trial. Qual Life Res. 2018 Apr; 27(4):1117.
  2. Chong J, Cohen M, Waubant E. Multiple sclerosis onset after granulocyte macrophage colony-stimulating factor withdrawal. Mult Scler Relat Disord. 2018 Feb; 20:178-180.
  3. Leibovitch EC, Lin CM, Billioux BJ, Graves J, Waubant E, Jacobson S. Prevalence of salivary human herpesviruses in pediatric multiple sclerosis cases and controls. Mult Scler. 2018 Mar 01; 1352458518765654.
  4. Giovannoni G, Hawkes C, Levy M, Waubant E. Are the high-costs of MS disease-modifying therapies justified? Mult Scler Relat Disord. 2018 Feb; 20:A3-A5.
  5. Hawkes C, Giovannoni G, Levy M, Waubant E. Editors' Welcome. Mult Scler Relat Disord. 2018 Feb; 20:A1-A2.
  6. Giovannoni G, Hawkes C, Levy M, Lublin F, Waubant E. Editors' Welcome. Mult Scler Relat Disord. 2018 Jan; 19:A1-A2.
  7. Waubant E. Effect of puberty on multiple sclerosis risk and course. Mult Scler. 2018 Jan; 24(1):32-35.
  8. Tremlett H, Waubant E. Gut microbiome and pediatric multiple sclerosis. Mult Scler. 2018 Jan; 24(1):64-68.
  9. Tremlett H, Waubant E. The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings. Neurotherapeutics. 2018 Jan; 15(1):102-108.
  10. Graves JS, Henry RG, Cree BAC, Lambert-Messerlian G, Greenblatt RM, Waubant E, Cedars MI, Zhu A. Ovarian aging is associated with gray matter volume and disability in women with MS. Neurology. 2018 Jan 16; 90(3):e254-e260.
  11. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018 Feb; 17(2):162-173.
  12. Nourbakhsh B, Revirajan N, Waubant E. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial. Contemp Clin Trials. 2018 Jan; 64:67-76.
  13. Waubant E, Giovannoni G, Hawkes C, Lublin F. Editors' Welcome. Mult Scler Relat Disord. 2017 Nov; 18:A1-A2.
  14. Graves JS, Barcellos LF, Simpson S, Belman A, Lin R, Taylor BV, Ponsonby AL, Dwyer T, Krupp L, Waubant E, van der Mei IAF. The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults. Mult Scler Relat Disord. 2018 Jan; 19:161-165.
  15. Azary S, Schreiner T, Graves J, Waldman A, Belman A, Guttman BW, Aaen G, Tillema JM, Mar S, Hart J, Ness J, Harris Y, Krupp L, Gorman M, Benson L, Rodriguez M, Chitnis T, Rose J, Barcellos LF, Lotze T, Carmichael SL, Roalstad S, Casper CT, Waubant E. Contribution of dietary intake to relapse rate in early paediatric multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018 Jan; 89(1):28-33.
  16. Lublin F, Giovannoni G, Hawkes C, Waubant E. Editors' Welcome. Mult Scler Relat Disord. 2017 Oct; 17:A1-A2.
  17. Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, Waldman A, Lotze T, Schreiner T, Belman A, Greenberg B, Weinstock-Guttman B, Aaen G, Tillema JM, Hart J, Caillier S, Ness J, Harris Y, Rubin J, Candee M, Krupp L, Gorman M, Benson L, Rodriguez M, Mar S, Kahn I, Rose J, Roalstad S, Casper TC, Shen L, Quach H, Quach D, Hillert J, Hedstrom A, Olsson T, Kockum I, Alfredsson L, Schaefer C, Barcellos LF, Waubant E. Genetic risk factors for pediatric-onset multiple sclerosis. Mult Scler. 2017 Oct 01; 1352458517733551.
  18. Gajofatto A, Nourbakhsh B, Benedetti MD, Waubant E. Performance of 2010 McDonald criteria and 2016 MAGNIMS guidelines in the diagnosis of primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. 2017 Sep 22.
  19. Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, Belman A, Weinstock-Guttman B, Aaen G, Tillema JM, Rodriguez M, Ness J, Harris Y, Graves J, Krupp L, Benson L, Gorman M, Moodley M, Rensel M, Goyal M, Mar S, Chitnis T, Schreiner T, Lotze T, Greenberg B, Kahn I, Rubin J, Waubant E. Examining the contributions of environmental quality to pediatric multiple sclerosis. Mult Scler Relat Disord. 2017 Nov; 18:164-169.
  20. Hawkes C, Giovannoni G, Lublin F, Waubant E. Editors' Welcome. Mult Scler Relat Disord. 2017 Aug; 16:A1-A2.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.